198 related articles for article (PubMed ID: 15746507)
1. Comparison of clozapine use in Maryland and in Victoria, Australia.
Conley RR; Kelly DL; Lambert TJ; Love RC
Psychiatr Serv; 2005 Mar; 56(3):320-3. PubMed ID: 15746507
[TBL] [Abstract][Full Text] [Related]
2. From conventional to atypical antipsychotics and back: dynamic processes in the diffusion of new medications.
Leslie DL; Rosenheck RA
Am J Psychiatry; 2002 Sep; 159(9):1534-40. PubMed ID: 12202274
[TBL] [Abstract][Full Text] [Related]
3. Prescribing second-generation antipsychotics and the evolving standard of care in Italy.
Barbui C; Danese A; Guaiana G; Mapelli L; Miele L; Monzani E; Percudani M;
Pharmacopsychiatry; 2002 Nov; 35(6):239-43. PubMed ID: 12518273
[TBL] [Abstract][Full Text] [Related]
4. Atypical antipsychotic use for adult outpatients in New Zealand's Auckland and Northland regions.
Wheeler A
N Z Med J; 2006 Jul; 119(1237):U2055. PubMed ID: 16862201
[TBL] [Abstract][Full Text] [Related]
5. Comparing the use and discontinuation of antipsychotics in clinical practice: an observational study.
Taylor M; Shajahan P; Lawrie SM
J Clin Psychiatry; 2008 Feb; 69(2):240-5. PubMed ID: 18363452
[TBL] [Abstract][Full Text] [Related]
6. Equivalent occupancy of dopamine D1 and D2 receptors with clozapine: differentiation from other atypical antipsychotics.
Tauscher J; Hussain T; Agid O; Verhoeff NP; Wilson AA; Houle S; Remington G; Zipursky RB; Kapur S
Am J Psychiatry; 2004 Sep; 161(9):1620-5. PubMed ID: 15337652
[TBL] [Abstract][Full Text] [Related]
7. Ethnic comparisons of antipsychotic use in schizophrenia.
Wheeler A; Humberstone V; Robinson E
Aust N Z J Psychiatry; 2008 Oct; 42(10):863-73. PubMed ID: 18777230
[TBL] [Abstract][Full Text] [Related]
8. Olanzapine vs. other antipsychotics in actual out-patient settings: six months tolerability results from the European Schizophrenia Out-patient Health Outcomes study.
Lambert M; Haro JM; Novick D; Edgell ET; Kennedy L; Ratcliffe M; Naber D
Acta Psychiatr Scand; 2005 Mar; 111(3):232-43. PubMed ID: 15701108
[TBL] [Abstract][Full Text] [Related]
9. [Current pharmacotherapy of schizophrenia].
Bitter I
Orv Hetil; 2004 Jan; 145(3):105-9. PubMed ID: 15027331
[TBL] [Abstract][Full Text] [Related]
10. Remission and relapse in the outpatient care of schizophrenia: three-year results from the Schizophrenia Outpatient Health Outcomes study.
Haro JM; Novick D; Suarez D; Alonso J; Lépine JP; Ratcliffe M;
J Clin Psychopharmacol; 2006 Dec; 26(6):571-8. PubMed ID: 17110813
[TBL] [Abstract][Full Text] [Related]
11. Relationship between antipsychotic medication treatment and new cases of diabetes among psychiatric inpatients.
Citrome L; Jaffe A; Levine J; Allingham B; Robinson J
Psychiatr Serv; 2004 Sep; 55(9):1006-13. PubMed ID: 15345760
[TBL] [Abstract][Full Text] [Related]
12. Patient characteristics and prescription patterns of atypical antipsychotics among patients with schizophrenia.
Ren XS; Kazis LE; Lee AF; Hamed A; Huang YH; Cunningham F; Miller DR
J Clin Pharm Ther; 2002 Dec; 27(6):441-51. PubMed ID: 12472984
[TBL] [Abstract][Full Text] [Related]
13. Antipsychotic exposure and type 2 diabetes among patients with schizophrenia: a matched case-control study of California Medicaid claims.
Lambert BL; Chou CH; Chang KY; Tafesse E; Carson W
Pharmacoepidemiol Drug Saf; 2005 Jun; 14(6):417-25. PubMed ID: 15786516
[TBL] [Abstract][Full Text] [Related]
14. Prior antipsychotic prescribing in patients currently receiving clozapine: a case note review.
Taylor DM; Young C; Paton C
J Clin Psychiatry; 2003 Jan; 64(1):30-4. PubMed ID: 12590620
[TBL] [Abstract][Full Text] [Related]
15. Early use of clozapine for poorly responding first-episode psychosis.
Agid O; Remington G; Kapur S; Arenovich T; Zipursky RB
J Clin Psychopharmacol; 2007 Aug; 27(4):369-73. PubMed ID: 17632221
[TBL] [Abstract][Full Text] [Related]
16. Pharmacy cost evaluation of risperidone, olanzapine, and quetiapine for the treatment of schizophrenia in acute care inpatient settings.
Mladsi DM; Grogg AL; Irish WD; Lopez RB; Degen K; Swann A; Nimsch CT
Curr Med Res Opin; 2004 Dec; 20(12):1883-93. PubMed ID: 15701206
[TBL] [Abstract][Full Text] [Related]
17. Drug prescription patterns in schizophrenia outpatients: analysis of data from a German health insurance fund.
Weinbrenner S; Assion HJ; Stargardt T; Busse R; Juckel G; Gericke CA
Pharmacopsychiatry; 2009 Mar; 42(2):66-71. PubMed ID: 19308881
[TBL] [Abstract][Full Text] [Related]
18. Risperidone and clozapine for treatment-resistant schizophrenia.
Dunayevich E; Chatterjee A
Am J Psychiatry; 1999 Jul; 156(7):1127; author reply 1127-8. PubMed ID: 10401486
[No Abstract] [Full Text] [Related]
19. Racial disparities in the use of second-generation antipsychotics for the treatment of schizophrenia.
Mallinger JB; Fisher SG; Brown T; Lamberti JS
Psychiatr Serv; 2006 Jan; 57(1):133-6. PubMed ID: 16399976
[TBL] [Abstract][Full Text] [Related]
20. Association of diabetes mellitus with use of atypical neuroleptics in the treatment of schizophrenia.
Sernyak MJ; Leslie DL; Alarcon RD; Losonczy MF; Rosenheck R
Am J Psychiatry; 2002 Apr; 159(4):561-6. PubMed ID: 11925293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
